BioTissue Signs National Agreement with EyePro GPO to Afford Members Exclusive Treatment Options for Ocular Surface Disease and Disorders

Group Purchasing Organization members now have streamlined access to BioTissue’s complete product portfolio to facilitate regenerative healing and help normalize the ocular surface quickly as an essential part of the pre-cataract surgical regimen

Miami, FL – October 12, 2021 – BioTissue, a TissueTech company and pioneer in the clinical application of human birth tissue allografts to promote regenerative healing for ocular surface disease and disorders, announced today that it has entered into a Vendor Agreement with EyePro Group Purchasing Organization (GPO), LLC. As such, GPO members can now take advantage of membership purchasing volume discounts to access Prokera^® biologic corneal bandages, AmnioGraft^® biologic ocular transplantation grafts, and the complete BioTissue product portfolio of regenerative healing solutions.

In addition to offering GPO members streamlined operational purchasing efficiencies and best-in-market pricing, BioTissue is also making available a host of value-added services at no additional cost to GPO members. These include virtual interactive webinars, real-time training sessions with BioTissue faculty members, and multidisciplinary cross-collaboration among peer practitioners to explore advances in healthcare delivery.

“This agreement further reinforces our desire to support the practice-building efforts of our clinical customers,” said TissueTech President and Chief Executive Officer Amy Tseng. “Strong vendor relationships are at the heart of everything we do. It fuels our approach to healthcare delivery and enables us to provide this market with innovative solutions that can advance patient recovery.”

Phil Meyer, Chief Operating Officer of EyePro, further reiterates the value of the BioTissue Vendor Agreement. “We look forward to a long, collaborative relationship with BioTissue as we continue to grow our network across the United States and establish ourselves as the leading group purchasing organization for the ophthalmology community.”

About TissueTech, Inc.

TissueTech, Inc. is an emerging biotechnology company and leader in regenerative medicine using human birth tissue. TissueTech’s pioneering amniotic membrane products are processed using its proprietary CryoTek^® cryopreservation technology, designed to retain the tissue’s structural and functional integrity. Today, TissueTech is breaking new ground with multiple Investigational New Drug clinical trials underway as the company pursues 351 biologics’ approval for products to treat patients’ unmet clinical needs. TissueTech is committed to empowering healthcare professionals with solutions to deliver optimal patient outcomes by fostering innovation through evidence-based science. Since its inception, clinicians have performed over 600,000 human implants with its products and published over 380 peer-reviewed studies supporting TissueTech’s platform technology. Learn more at https://biotissue.com.

About BioTissue

BioTissue is a TissueTech, Inc. company. It is pioneering the clinical application of human birth tissue to promote regenerative healing for ocular surface disease and disorders. The BioTissue portfolio of cryopreserved amniotic membrane products are processed using its proprietary CryoTek^® technology to retain the birth tissue’s structural and functional integrity. As a leader in clinical research, BioTissue has been facilitating optimal clinical outcomes, solving previously unmet clinical and patient needs, and positively impacting patients’ lives since 1997. Connect with BioTissue on our Website, Physician Portal, Facebook, LinkedIn, Instagram, and Twitter, or through your local sales professional.

About EyeProGPO, LLC

EyeProGPO is an ophthalmology-focused group purchasing organization made up of members who are either or both ophthalmology practices and/or ophthalmic ASC’s, joining together to realize cost savings and workflow efficiencies by utilizing aggregated membership purchasing volume to negotiate discounts with manufacturers, distributors, and vendors to lower the cost of healthcare.  EyeProGPO also collects data and assists vendors in their sales analyses to allow greater efficiency and reduce costs.